Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs SANOFI INDIA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA SANOFI INDIA ASTRAZENECA PHARMA/
SANOFI INDIA
 
P/E (TTM) x 91.1 22.5 404.9% View Chart
P/BV x 16.5 6.0 273.3% View Chart
Dividend Yield % 0.3 8.6 3.4%  

Financials

 ASTRAZENECA PHARMA   SANOFI INDIA
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-22
SANOFI INDIA
Dec-21
ASTRAZENECA PHARMA/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs4,5809,300 49.2%   
Low Rs2,5297,344 34.4%   
Sales per share (Unadj.) Rs322.21,283.8 25.1%  
Earnings per share (Unadj.) Rs24.6410.1 6.0%  
Cash flow per share (Unadj.) Rs31.4439.0 7.2%  
Dividends per share (Unadj.) Rs10.00490.00 2.0%  
Avg Dividend yield %0.35.9 4.8%  
Book value per share (Unadj.) Rs203.8940.3 21.7%  
Shares outstanding (eoy) m25.0023.03 108.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x11.06.5 170.2%   
Avg P/E ratio x144.320.3 710.8%  
P/CF ratio (eoy) x113.119.0 596.8%  
Price / Book Value ratio x17.48.9 197.1%  
Dividend payout %40.6119.5 34.0%   
Avg Mkt Cap Rs m88,863191,661 46.4%   
No. of employees `000NANA-   
Total wages/salary Rs m2,3024,339 53.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m8,05629,566 27.2%  
Other income Rs m148746 19.8%   
Total revenues Rs m8,20430,312 27.1%   
Gross profit Rs m86212,515 6.9%  
Depreciation Rs m170667 25.4%   
Interest Rs m1018 52.8%   
Profit before tax Rs m83012,576 6.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2143,132 6.8%   
Profit after tax Rs m6169,444 6.5%  
Gross profit margin %10.742.3 25.3%  
Effective tax rate %25.824.9 103.7%   
Net profit margin %7.631.9 23.9%  
BALANCE SHEET DATA
Current assets Rs m7,65336,791 20.8%   
Current liabilities Rs m3,92322,908 17.1%   
Net working cap to sales %46.347.0 98.6%  
Current ratio x2.01.6 121.5%  
Inventory Days Days61189 32.5%  
Debtors Days Days3918 220.6%  
Net fixed assets Rs m2,12018,762 11.3%   
Share capital Rs m50230 21.7%   
"Free" reserves Rs m5,04421,425 23.5%   
Net worth Rs m5,09421,655 23.5%   
Long term debt Rs m00-   
Total assets Rs m9,77355,553 17.6%  
Interest coverage x88.4699.7 12.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.5 154.9%   
Return on assets %6.417.0 37.6%  
Return on equity %12.143.6 27.7%  
Return on capital %16.558.2 28.3%  
Exports to sales %00-   
Imports to sales %31.719.4 163.7%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m2,5525,723 44.6%   
Fx inflow Rs m4423,856 11.5%   
Fx outflow Rs m2,5525,723 44.6%   
Net fx Rs m-2,110-1,867 113.0%   
CASH FLOW
From Operations Rs m1,0085,588 18.0%  
From Investments Rs m476,308 0.8%  
From Financial Activity Rs m-95-8,490 1.1%  
Net Cashflow Rs m9613,406 28.2%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 60.4 124.2%  
Indian inst/Mut Fund % 3.8 26.5 14.4%  
FIIs % 2.5 8.3 30.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 39.6 63.1%  
Shareholders   49,085 73,734 66.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    LUPIN    ZYDUS LIFESCIENCES    


More on ASTRAZENECA PHARMA vs Sanofi India

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ASTRAZENECA PHARMA vs Sanofi India Share Price Performance

Period ASTRAZENECA PHARMA Sanofi India S&P BSE HEALTHCARE
1-Day -0.02% -0.42% 0.23%
1-Month 2.02% 1.76% 0.36%
1-Year 3.02% -29.47% -6.87%
3-Year CAGR 7.94% -6.79% 20.16%
5-Year CAGR 24.01% 5.23% 11.07%

* Compound Annual Growth Rate

Here are more details on the ASTRAZENECA PHARMA share price and the Sanofi India share price.

Moving on to shareholding structures...

The promoters of ASTRAZENECA PHARMA hold a 75.0% stake in the company. In case of Sanofi India the stake stands at 60.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASTRAZENECA PHARMA and the shareholding pattern of Sanofi India.

Finally, a word on dividends...

In the most recent financial year, ASTRAZENECA PHARMA paid a dividend of Rs 10.0 per share. This amounted to a Dividend Payout ratio of 40.6%.

Sanofi India paid Rs 490.0, and its dividend payout ratio stood at 119.5%.

You may visit here to review the dividend history of ASTRAZENECA PHARMA, and the dividend history of Sanofi India.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Mark Mobius on Cryptos | Dharmaj Crop IPO Fully Subscribed on Debut | Top Buzzing Stocks Today(Pre-Open)

On Monday, Indian share markets hit new records following heavy gains from Reliance and other oil marketing companies as crude prices fell.